Section Arrow
Quote
MEDP.NASDAQ
- Medpace Holdings
Quotes are at least 15-min delayed:2025/07/03 01:50 EDT
Last
 326.03
+4.965 (+1.55%)
Day High 
328.06 
Prev. Close
321.065 
1-M High
326.745 
Volume 
378.97K 
Bid
290
Ask
330
Day Low
318.03 
Open
319.4 
1-M Low
291.28 
Market Cap 
9.23B 
Currency USD 
P/E 24.51 
%Yield -- 
10-SMA 309.74 
20-SMA 305.8 
50-SMA 301.64 
52-W High 459.77 
52-W Low 250.05 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
13.10/13.13
Enterprise Value
9.35B
Balance Sheet
Book Value Per Share
20.65
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
2.11B
Operating Revenue Per Share
61.98
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.23+0.15+2.95%879PE
BIAFbioAffinity Technologies0.29+0.0265+10.06%-- 
DHRDanaher Corp202.5+1.4+0.70%38.97PE
OPKOPKO Health1.34+0.01+0.75%-- 
TMOThermo Fisher Scientific427.76+6.29+1.49%24.72PE
Quotes are at least 15-min delayed：2025/07/03 01:50 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.